FDA Categorization Of Hybrid Medical Products Suggested By Science Board
This article was originally published in The Gray Sheet
Executive Summary
FDA should consider developing a system to categorize hybrid technologies that would help the agency evaluate which products might raise ethical concerns, FDA Science Board panel members recommended.